Hydroxyzine Pamoate Capsule
Product Images NDC 51407-002

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Hydroxyzine Pamoate (NDC 51407-002). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Golden State Medical Supply, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

51407-001-01lb.jpg (51407 001 01lb)

Each capsule contains HydrOXYzine equivalent to 25 mg Hydroxyzine. The usual dosage for adults is 25 mg t.i.d. to 100 mg q.i.d. For children, under 6 years: 50 mg daily in divided doses, and over 6 years: 50 to 100 mg daily in divided doses. It is recommended to see the accompanying prescribing information. The medication should be stored in tight, light-resistant containers at 20° - 25°C (68° - 77°F). These Capsules are Tartrazine dye-free. Marketed by GSMS, Incorporated, these capsules should be kept out of the reach of children.*

FDA Label Image

51407-002-01lb.jpg (51407 002 01lb)

This text provides information about a medication in capsule form containing Hydroxyzine Pamoate equivalent to 50 mg Hydroxyzine Hydrochloride. The usual dosage for this medication is specified for children under 6 years and over 6 years. It also gives instructions on storage and mentions that it is Tartrazine dye free. The capsules are to be dispensed in light-resistant containers and kept out of reach of children. This medication is manufactured by GSMS, Incorporated in Camarillo, CA, USA.*

FDA Label Image

Structure (Bdb22fcc B768 493e A8e0 09975b3aba6a 01)

FDA Label Image

Image (Bdb22fcc B768 493e A8e0 09975b3aba6a 02)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.